Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Recruiting
1,310 enrolled
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Completed
573 enrolled
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes
Recruiting
2,000 enrolled
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Active not recruiting
10,000 enrolled
Foucault
Completed
133 enrolled
NOLA (NeuWave Observational Liver Ablation) Registry
Terminated
1,254 enrolled 13 charts
Molecular Epidemiology of Biliary Tree Cancers
Recruiting
1,500 enrolled
CHANCE2202
Completed
941 enrolled
CHANCE2201
Completed
1,244 enrolled
ARCBile
Completed
729 enrolled
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Enrolling by invitation
300 enrolled
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitation
64,277 enrolled
RealCHALLENGE
Recruiting
250 enrolled
Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.
Not yet recruiting
46 enrolled
ОС26
Not yet recruiting
82 enrolled
KIA-Korekt
Recruiting
910 enrolled
Young-Onset Colorectal Cancer
Active not recruiting
818 enrolled
iGreenGO
Recruiting
360 enrolled
CHALNA2
Recruiting
710 enrolled
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Recruiting
400 enrolled
Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Not yet recruiting
158 enrolled
IPEX
Not yet recruiting
600 enrolled
GOLD
Active not recruiting
109 enrolled
COBRA
Active not recruiting
121 enrolled
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
Recruiting
100 enrolled
REFINE-IO
Recruiting
300 enrolled
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
Recruiting
250 enrolled
Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
Not yet recruiting
140 enrolled
Shanghai Clinical Cohort - Esophageal Cancer
Completed
2,116 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Collection of Blood From Patients With Cancer
Recruiting
1,750 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Recruiting
3,500 enrolled
Esophageal Cancer Risk Registry
Recruiting
7,000 enrolled
Genomic Services Research Program
Recruiting
5,000 enrolled
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Active not recruiting
132 enrolled
Safety and Efficacy of Trastuzumab BS
Completed
8 enrolled 8 charts
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Recruiting
400 enrolled
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
Terminated
129 enrolled
CyDESA
Completed
846 enrolled
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Active not recruiting
500 enrolled
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Recruiting
240 enrolled
An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.
Not yet recruiting
1,000 enrolled
StomachCancer
Completed
50 enrolled
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
Not yet recruiting
450 enrolled
Functional and Respiratory Predictors of Early Postoperative Outcomes
Recruiting
42 enrolled
MIND-PANC
Not yet recruiting
320 enrolled
ANGIOPREDICT. ICORG 12-16, V3
Completed
76 enrolled
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Active not recruiting
757 enrolled
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Recruiting
200 enrolled